Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ionis Pharmaceuticals Q4 Adjusted EPS $0.12 May Not Be Comparable To $(0.83) Estimate, Sales $325.00M Not Be Comparable To $174.76M Estimate

Author: Benzinga Newsdesk | February 21, 2024 08:04am

Posted In: IONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist